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Background: Deaths from coronary heart disease (CHD) have been decreasing in most Western countries over the
last few decades. In contrast, a flattening of the decrease in mortality has been recently reported among younger
age groups in some countries. We aimed to determine whether the decrease in CHD mortality is flattening among
Swedish young adults.
Methods: We examined trends in CHD mortality in Sweden between 1987 and 2009 among persons aged 35 to
84 years using CHD mortality data from the Swedish National Register on Cause of Death. Annual percent changes
in rates were examined using Joinpoint software.
Results: Overall, CHD mortality rates decreased by 67.4% in men and 65.1% in women. Among men aged
35–54 years, there was a modest early attenuation from a marked initial decrease. In the oldest women aged
75–84 years, an attenuation in the mortality decrease was observed from 1989 to 1992, followed by a decrease,
as in all other age groups.
Conclusions: In Sweden, coronary heart disease deaths are still falling. We were unable to confirm a flattening of
the decline in young people. Death rates continue to decline in men and women across all age groups, albeit at
a slower pace in younger men since 1991. Continued careful monitoring of CHD mortality trends in Sweden is
required, particularly among young adults.
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Cardiovascular disease is the leading cause of death in
women in Europe and the main cause of death in European
men, except in Spain, France, Israel, San Marino, Slovenia
and the Netherlands [1]. In Europe, a north-east to
south-west gradient has been reported where mortality
from coronary heart disease (CHD) is lower in the south-
west regions of Europe [2].
In the Western world, a decrease in CHD mortality
has been observed in the last 20 to 30 years, as a result
of population trends in risk factors, as well as improved
treatment and prevention [3-5]. However, in the last 10
years, research has shown a flattening in the decrease in
mortality among younger adults [6-10], or no decline at* Correspondence: johanna.berg@gu.se
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reproduction in any medium, provided the orall among people aged less than 55 years [11]. In con-
trast, a study from the Netherlands showed an initial
flattening of the mortality decline among young people
followed by a decrease [12]. In Sweden, overall mortality
rates from CHD have been declining since the 1980s [4].
Given that a flattening in the decline in CHD mortality
in some countries has been demonstrated particularly
among young people, the present study aimed to investi-
gate whether this is occurring also in the Swedish popu-
lation. Recent trends have not previously been reported
for separate age groups in Sweden.Methods
We conducted a population-based observational study
based on CHD mortality data from the Swedish National
Register on Cause of Death, including the total population
aged 35–84 years. Information on population count was
acquired from the national board of Statistics Sweden. We
limited our analysis to people aged 35–84 years andd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Age-standardised trends in coronary heart
disease mortality among Swedish women from 1987 to
2009: joinpoint analysis
Age group (years)
and periods
No of deaths
(max-min)1
Rates per 105
(max-min)2
Annual percentage
change (95% CI)
35–54
1987–2009 104–63 11.6 –5.2 −3.1* (−3.7 to −2.4)
55–64:
1987–2009 482–216 107–39.1 −4.7* (−5.1 to −4.2)
65–74:
1987–1996 1978–1346 417–289 −4.3* (−5.0 to −3.5)
1996–2009 1346–588 294–128 −5.7* (−6.3 to −5.2)
75–84:
1987–1989 4928–4480 1617–1418 −6.5* (−10.9 to −1.8)
1989–1992 4518–4421 1418–1360 −1.5 (−6.4 to 3.7)
1992–2006 4421–2428 1360–729 −4.5* (−4.8 to −4.2)
2006–2009 2428–1855 729–578 −6.9* (−10.5 to −3.2)
35–84:
1987–1993 7496–6376 301.1–244.2 −3.4* (−4.4 to −2.4)
1993–2009 6376–2758 244.2–105.1 −4.8* (−5.1 to −4.5)
*Annual Percentage Change (APC) is significantly different from zero
at alpha = 0.05.
1The total number of deaths in the age group for each particular year.
2Comparison of the mortality rates in each age group and time interval.
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and 75–84 years. To assign cause of death, we used
the International Classification of Diseases (ICD)-9 codes
410–414 for 1987 to 1996 and ICD-10 codes I20-I25 for
1997 to 2009. We adjusted the death rates for age with the
direct method [13] using the Swedish population of the
year 2010.
To analyse the mortality rates over time, we used join-
point regression for estimation of the annual percentage
change and to identify the specific years when significant
changes in the trends occurred (Joinpoint Regression
Program, version 3.3.1. April 2008; Statistical Research
and Applications Branch, National Cancer Institute).
Joinpoint regression analysis was originally applied in
cancer mortality analysis although recently also in CHD
mortality trend analysis [8-10]. We fitted the data in a
log-linear model and set the number of possible join-
points between 0 and 3. The program analysed if there
was a change in the trend curve, a suggested joinpoint
where the annual percent change became inconstant.
The true number of joinpoints was verified with a permu-
tation test to obtain a significance level. For each estimate
of mean annual percentage change, 95% confidence inter-
vals (CIs) were calculated. Variance was analysed with the
Poisson model using count. For confidentiality, all per-
sonal identity numbers were replaced by codes. The pro-
tocol was approved by the Ethics board of the University
of Gothenburg.Table 2 Age-standardised trends in coronary heart
disease mortality among Swedish men from 1987 to
2009: joinpoint analysis
Age group (years)
and periods
No of deaths
(max-min)1
Rates per 105
(max-min)2
Annual percentage
change (95% CI)
35–54:
1987–1991 689–545 68.7–47.4 −8.1* (−11.5 to −4.6)
1991–2009 578–282 47.4–22.5 −3.9* (−4.4 to −3.4)
55–64:Results and discussion
CHD mortality trends in the total population
In Sweden, the overall age-adjusted mortality rates from
CHD decreased by 65.1% in women from 1987 to 2009
(Figure 1, Table 1). When analysed with joinpoint the
average annual rate of decline over the 23-year period
was 3.4% from 1987 to 1993 and 4.8% from 1993 to 2009.
In men, the overall decrease in CHD mortality was 67.4%
from 1987 to 2009 (Figure 1, Table 2). The average annual0
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Figure 1 Trends in age-adjusted mortality rates from coronary
heart disease mortality for adults aged 35–84 years in Sweden
from 1987 to 2009.
1987–2009 1992–796 465–132 −5.6* (−5.9 to −5.4)
65–74:
1987–1997 5099–2923 1260–768 −4.6* (−5.1 to −4.1)
1997–2009 2923–1545 768–350 −6.1* (−6.6 to −5.6)
75–84:
1987–1995 6284–5225 2927–2298 −3.1* (−3.9 to −2.4)
1995–2009 5320–2714 2299–1119 −4.6* (−5.0 to −4.2)
35–84:
1987–1995 13935–10501 644.2–461.9 −4.2* (−4.7 to −3.6)
1995–2009 10501–5339 461.9–210.2 −5.1* (−5.4 to −4.8)
*Annual Percentage Change (APC) is significantly different from zero
at alpha = 0.05.
1The total number of deaths in the age group for each particular year.
2Comparison of the mortality rates in each age group and time interval.
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1995 to 2009. Accordingly, the rate of decline of the over-
all CHD mortality rates has been more rapid in both sexes
during the latter part of the period.
Age-specific CHD mortality trends
When considering age-specific trends in mortality rates
from 1987 among women aged 35–54 years, an increase
was observed during the first few years, followed by a
decrease (Figure 2, Table 1), and the rate varied from
year to year. Apparent increases in mortality rates for
young women for some years were observed, followed
by decreases. The average annual change was 3.1% (95%
CI: 3.7 to 2.4) from 1987 until 2009, with no significant
joinpoint. In women aged 55–64 years, non-significant
apparent attenuations were observed between 1989 to
1991, 1997 to 1999 and 2003 to 2005. Overall, the aver-
age annual change was 4.7% (95% CI: 5.1 to 4.2), with no
significant change in the trend. The mortality continued
to decline in 65–74 year old women, accelerating slightly
after 1996. There was a brief flattening in the rate of
decrease from 1989 to 1992 for the oldest women, after
which mortality decreased.
Among the youngest men (35–54 years), there was a
modest attenuation in CHD mortality rate between 1991
and 2009 from a very marked initial decrease (Figure 2,
Table 2). In men aged 55–64 years, no flattening in mor-
tality rate was observed. Among men aged 65–74 years
and 75–84 years, both groups displayed joinpoints, with
an accelerated decrease after the mid-90s.
In this study of the total Swedish population aged
35–84 years over a period of 23 years, we observed a
continuing decrease in CHD mortality among men
and women in all age groups over the last 2 decades,
which is satisfactory. This is in contrast to some other
countries, where a flattening in the decrease in CHD
mortality has been observed among younger people
[6-9,12]. Nevertheless, in the present study, a slower rateFigure 2 Trends in age-specific mortality rates from coronary heart d
1987 to 2009.of decrease in CHD mortality was observed in men aged
35–54 years after 1991. In women aged 35–54 years, the
age-adjusted mortality fluctuated, largely due to a limited
number of events, with random variation, but there was
no statistically significant change in the rate of annual
change.
An estimation model has been used to estimate the
impact of treatment and risk factors on CHD mortality
[3-5,14]. Similar to findings from the UK, Ireland, the
US, and other Western high-income countries, up to
two thirds of the decrease in CHD mortality in Sweden
from 1986 to 2002 can be explained by improved risk
factors in the population (lower serum cholesterol, lower
rates of smoking and lower blood pressure). The decrease
in risk factors has resulted in a lower CHD incidence [15].
Improvement in medical interventions, including better
treatment of acute myocardial infarction and secondary
prevention can explain one third of the decrease in CHD
mortality [4]. Because many fatalities occur outside hos-
pital [16] in people with no known prior disease, the scope
for improvement by improved care in the acute stage of
the disease is limited.
The paradox of the decrease in CHD mortality ob-
served in parallel with the ongoing obesity epidemic has
been discussed [17,18]. Although obesity is linked to
cardiovascular risk it seems to be associated with better
survival. The paradox could partly be explained by a
lower amount of risk factors even among the obese
population [4,19]. It has further been suggested that the
survival effects of obesity might be postponed through a
gradual process of cardiac remodeling [20] or that obese
patients present with CHD at a younger age and receive
more effective treatment [21]. In Sweden, one-third of
women and half of the men are overweight or obese, with
obesity rates increasing in the last two decades [19,22],
more among men than among women. Regardless, CHD
mortality rates in Sweden are below those of many other
countries [23]. This increasing obesity will probably leadisease mortality for adults aged 35–84 years in Sweden from
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creasing the risk factor burden. However, there may be a
recent plateauing in the rate of obesity [24], and addition-
ally, the incidence of type-2-diabetes mellitus and hyper-
tension in the population has not appreciably increased
[25-27]. Even so, there is a time lag between the incidence
of obesity and CHD mortality and development of meta-
bolic effects of obesity leading to atherosclerosis. Ultim-
ately, if obesity trends in Sweden are not reversed, it
appears unlikely that this reassuringly downward trend for
CHD mortality for all ages in Sweden will continue.
The decline in CHD mortality in Sweden and other
Western high income countries does not apply to all seg-
ments of the population. Data from 6 countries of West-
ern Europe from the mid-80s to the mid-90s, including
Sweden, show faster proportional mortality declines in
higher socioeconomic groups, partly due to more rapid
proportional mortality declines for cardiovascular diseases
[28]. In the current study, we did not have data on social
position, but other studies have shown a widening gap, at
least with respect to population risk factors in Sweden
[29]. Therefore, reducing these socioeconomic inequalities
and providing access to prevention and modern treatment
for all groups are crucial to secure a continuing decline in
the mortality of CHD. Finally, continuing success in the
battle against CHD is by no means ensured. Fad diets,
with low carbohydrate – high fat content, have become in-
creasingly popular in Sweden [30], and rising cholesterol
levels after 2007 have recently been reported [31]. This
finding warrants continued vigilance with respect to CHD
mortality trends.
There are some limitations to the present study, in-
cluding the reliance on data collected for administrative
purposes, with a potential risk of misclassification. Re-
cent findings from our group have highlighted the fact
that 3 out of 4 CHD deaths occur out of hospital, and
that this proportion is even greater among younger
people [16]. Still, autopsy rates for out-of-hospital deaths
are relatively high, particularly among younger subjects,
where at least 80% of fatal cases are subjected to an aut-
opsy, and accordingly, it is unlikely that misclassification
could explain a lack of attenuation in CHD death rates.
Additionally, the youngest age group, particularly women,
comprises few deaths annually, which results in some fluc-
tuations in the mortality trends that can be overstated.
However, when these trends were analysed with joinpoint
regression, they were not significant. The strengths of this
study are that it covered the whole Swedish population for
an extended period of time.
Conclusions
In conclusion, over the last two decades, CHD mortality
has been decreasing by approximately two-thirds in all
age groups in Sweden. We were unable to confirm aflattening of the decline in young people. Prior research
has shown that this is explained by improvements in risk
factors in the population, subsequent lower incidence
and by better medical treatment over a range of modal-
ities. Unlike several other countries, Sweden, as yet, has
not observed a clear flattening in these favourable
trends. Despite this, it is apparent that decreasing trends
are not guaranteed and recent reports on increasing
cholesterol levels from 2008 and onwards are deeply
concerning. Continued careful monitoring of CHD mor-
tality trends in Sweden is required, particularly among
young adults.
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